[1] |
陆新章, 张梅, 娄颜坤, 等. 利用基因编辑技术进行猪异种器官移植及人类疾病模型研究的进展[J]. 上海农业学报, 2021, 37(1): 136-144. DOI: 10.15955/j.issn1000-3924.2021.01.23.LU XZ, ZHANG M, LOU YK, et al. Genome editing technologies for xenotransplantation and disease model in pigs[J]. Acta Agric Shanghai, 2021, 37(1): 136-144. DOI: 10.15955/j.issn1000-3924.2021.01.23.
|
[2] |
COOPER DKC, HARA H, IWASE H, et al. Pig kidney xenotransplantation: progress toward clinical trials[J]. Clin Transplant, 2021, 35(1): e14139. DOI: 10.1111/ctr.14139.
|
[3] |
ADAMS AB, KIM SC, MARTENS GR, et al. Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival[J]. Ann Surg, 2018, 268(4): 564-573. DOI: 10.1097/SLA.0000000000002977.
|
[4] |
KIM SC, MATHEWS DV, BREEDEN CP, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion[J]. Am J Transplant, 2019, 19(8): 2174-2185. DOI: 10.1111/ajt.15329.
|
[5] |
CLEVELAND DC, JAGDALE A, CARLO WF, et al. The genetically engineered heart as a bridge to allotransplantation in infants just around the corner?[J]. Ann Thorac Surg, 2022, 114(2): 536-544. DOI: 10.1016/j.athoracsur.2021.05.025.
|
[6] |
LÄNGIN M, MAYR T, REICHART B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation[J]. Nature, 2018, 564(7736): 430-433. DOI: 10.1038/s41586-018-0765-z.
|
[7] |
FIRL DJ, MARKMANN JF. Measuring success in pig to non-human-primate renal xenotransplantation: systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants[J]. Am J Transplant, 2022, 22(6): 1527-1536. DOI: 10.1111/ajt.16994.
|
[8] |
CARVALHO OLIVEIRA M, VALDIVIA E, VERBOOM M, et al. Generating low immunogenic pig pancreatic islet cell clusters for xenotransplantation[J]. J Cell Mol Med, 2020, 24(9): 5070-5081. DOI: 10.1111/jcmm.15136.
|
[9] |
VOURC'H M, DAVID G, GABORIT B, et al. Pseudomonas aeruginosa infection impairs NKG2D-dependent NK cell cytotoxicity through regulatory T-cell activation[J]. Infect Immun, 2020, 88(12): e00363-20. DOI: 10.1128/IAI.00363-20.
|
[10] |
TAKEUCHI K, ARIYOSHI Y, SHIMIZU A, et al. Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig-to-baboon xenotransplantation[J]. Xenotransplantation, 2021, 28(6): e12708. DOI: 10.1111/xen.12708.
|
[11] |
ZHOU Q, LI T, WANG K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022, 13: 928173. DOI: 10.3389/fimmu.2022.928173.
|
[12] |
YUE Y, XU W, KAN Y, et al. Extensive germline genome engineering in pigs[J]. Nat Biomed Eng, 2021, 5(2): 134-143. DOI: 10.1038/s41551-020-00613-9.
|
[13] |
GAO Y, SHAN W, GU T, et al. Daratumumab prevents experimental xenogeneic graft-versus-host disease by skewing proportions of T cell functional subsets and inhibiting T cell activation and migration[J]. Front Immunol, 2021, 12: 785774. DOI: 10.3389/fimmu.2021.785774.
|
[14] |
BOCKERMANN R, JÄRNUM S, RUNSTRÖM A, et al. Imlifidase-generated single-cleaved IgG: implications for transplantation[J]. Transplantation, 2022, 106(7): 1485-1496. DOI: 10.1097/TP.0000000000004031.
|
[15] |
IWASE H, EKSER B, HARA H, et al. Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition[J]. Xenotransplantation, 2014, 21(1): 72-83. DOI: 10.1111/xen.12073.
|
[16] |
CAO PP, WANG BF, NORTON JE, et al. Studies on activation and regulation of the coagulation cascade in chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2022, 150(2): 467-476. DOI: 10.1016/j.jaci.2022.02.018.
|
[17] |
ADAMS AB, LOVASIK BP, FABER DA, et al. Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation[J]. Ann Surg, 2021, 274(3): 473-480. DOI: 10.1097/SLA.0000000000004996.
|
[18] |
IWASE H, HARA H, EZZELARAB M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J]. Xenotransplantation, 2017, 24(2): 10.1111/xen. 12293. DOI: 10.1111/xen.12293.
|
[19] |
LI J, HARA H, WANG Y, et al. Evidence for the important role of inflammation in xenotransplantation[J]. J Inflamm (Lond), 2019, 16: 10. DOI: 10.1186/s12950-019-0213-3.
|
[20] |
IWASE H, LIU H, LI T, et al Therapeutic regulation of systemic inflammation in xenograft recipients[J]. Xenotransplantation, 2017, 24(2): 10.1111/xen. 12296. DOI: 10.1111/xen.12296.
|
[21] |
JAFFAR J, MCMILLAN L, WILSON N, et al. Coagulation factor-XⅡ induces interleukin-6 by primary lung fibroblasts: a role in idiopathic pulmonary fibrosis?[J]. Am J Physiol Lung Cell Mol Physiol, 2022, 322(2): L258-L272. DOI: 10.1152/ajplung.00165.2021.
|
[22] |
EZZELARAB MB, COOPER DKC. Systemic inflammation in xenograft recipients (SIXR): a new paradigm in pig-to-primate xenotransplantation?[J]. Int J Surg, 2015, 23(Pt B): 301-305. DOI: 10.1016/j.ijsu.2015.07.643.
|
[23] |
BEAVERS DP, KRITCHEVSKY SB, GILL TM, et al. Elevated IL-6 and CRP levels are associated with incident self-reported major mobility disability: a pooled analysis of older adults with slow gait speed[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(12): 2293-2299. DOI: 10.1093/gerona/glab093.
|
[24] |
ZHANG G, IWASE H, LI Q, et al. The role of interleukin-6 (IL-6) in the systemic inflammatory response in xenograft recipients and in pig kidney xenograft failure[J]. Front Immunol, 2021, 12: 788949. DOI: 10.3389/fimmu.2021.788949.
|
[25] |
LI T, JIANG H, LIU H, et al. Extracellular histones and xenotransplantation[J]. Xenotransplantation, 2020, 7(5): e12618. DOI: 10.1111/xen.12618.
|
[26] |
TANG T, CHENG X, TRUONG B, et al. Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint[J]. Pharmacol Ther, 2021, 219: 107709. DOI: 10.1016/j.pharmthera.2020.107709.
|
[27] |
ANGELI F, VERDECCHIA P, SAVONITTO S, et al. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention[J]. Clin Chem Lab Med, 2021, 60(1): 118-126. DOI: 10.1515/cclm-2021-0817.
|
[28] |
BIKHET M, IWASE H, YAMAMOTO T, et al. What therapeutic regimen will be optimal for initial clinical trials of pig organ transplantation?[J]. Transplantation, 2021, 105(6): 1143-1155. DOI: 10.1097/TP.0000000000003622.
|
[29] |
MICHAELS AJ, STOPPATO M, FLORES WJ, et al. Anti-CD40 antibody 2C10 binds to a conformational epitope at the CD40-CD154 interface that is conserved among primate species[J]. Am J Transplant, 2020, 20(1): 298-305. DOI: 10.1111/ajt.15574.
|
[30] |
VINCENTI F, KLINTMALM G, YANG H, et al. A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation[J]. Am J Transplant, 2020, 20(1): 172-180. DOI: 10.1111/ajt.15560.
|
[31] |
ESPIÉ P, HE Y, KOO P, et al. First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody[J]. Am J Transplant, 2020, 20(2): 463-473. DOI: 10.1111/ajt.15661.
|
[32] |
KIM SC, WAKWE W, HIGGINBOTHAM LB, et al. Fc-silent anti-CD154 domain antibody effectively prevents nonhuman primate renal allograft rejection[J]. Am J Transplant, 2017, 17(5): 1182-1192. DOI: 10.1111/ajt.14197.
|
[33] |
PORRETT PM, ORANDI BJ, KUMAR V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model[J]. Am J Transplant, 2022, 22(4): 1037-1053. DOI: 10.1111/ajt.16930.
|
[34] |
ZHANG Z, HARA H, LONG C, et al. Immune responses of HLA highly sensitized and nonsensitized patients to genetically engineered pig cells[J]. Transplantation, 2018, 102(5): e195-e204. DOI: 10.1097/TP.0000000000002060.
|
[35] |
LI T, FENG H, DU J, et al. Serum antibody binding and cytotoxicity to pig cells in Chinese subjects: relevance to clinical renal xenotransplantation[J]. Front Immunol, 2022, 13: 844632. DOI: 10.3389/fimmu.2022.844632.
|
[36] |
LADOWSKI JM, HARA H, COOPER DKC. The role of SLAs in xenotransplantation[J]. Transplantation, 2021, 105(2): 300-307. DOI: 10.1097/TP.0000000000003303.
|
[37] |
LI Q, HARA H, ZHANG Z, et al. Is sensitization to pig antigens detrimental to subsequent allotransplantation?[J]. Xenotransplantation, 2018, 25(3): e12393. DOI: 10.1111/xen.12393.
|
[38] |
HARTLINE CB, CONNER RL, JAMES SH, et al. Xenotransplantation panel for the detection of infectious agents in pigs[J]. Xenotransplantation, 2018, 25(4): e12427. DOI: 10.1111/xen.12427.
|
[39] |
FISHMAN JA. Infectious disease risks in xenotransplantation[J]. Am J Transplant, 2018, 18(8): 1857-1864. DOI: 10.1111/ajt.14725.
|
[40] |
DENNER J. The porcine cytomegalovirus (PCMV) will not stop xenotransplantation[J]. Xenotransplantation, 2022, 29(3): e12763. DOI: 10.1111/xen.12763.
|
[41] |
MA Y, JIA J, FAN R, et al. Screening and identification of the first non-CRISPR/Cas9-treated Chinese miniature pig with defective porcine endogenous retrovirus pol genes[J]. Front Immunol, 2022, 12: 797608. DOI: 10.3389/fimmu.2021.797608.
|
[42] |
BOSE S, VOLPATTI LR, THIONO D, et al. A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells[J]. Nat Biomed Eng, 2020, 4(8): 814-826. DOI: 10.1038/s41551-020-0538-5.
|
[43] |
HINRICHS A, KESSLER B, KUROME M, et al. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver[J]. Mol Metab, 2018, 11: 113-128. DOI: 10.1016/j.molmet.2018.03.006.
|
[44] |
IWASE H, BALL S, ADAMS K, et al. Growth hormone receptor knockout: relevance to xenotransplantation[J]. Xenotransplantation, 2021, 28(2): e12652. DOI: 10.1111/xen.12652.
|
[45] |
ASHTON-CHESS J, ROUSSEL JC, BERNARD P, et al. The effect of immunoglobulin immunadsorptions on delayed xenograft rejection of human CD55 transgenic pig kidneys in baboons[J]. Xenotransplantation, 2003, 10(6): 552-561. DOI: 10.1034/j.1399-3089.2003.00052.x.
|
[46] |
BALDAN N, RIGOTTI P, CALABRESE F, et al. Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events?[J]. Am J Transplant, 2004, 4(4): 475-481. DOI: 10.1111/j.1600-6143.2004.00407.x.
|
[47] |
ASHTON-CHESS J, MEURETTE G, KARAM G, et al. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide[J]. Xenotransplantation, 2004, 11(2): 112-122. DOI: 10.1111/j.1399-3089.2004.00040.x.
|
[48] |
COZZI E, SIMIONI P, BOLDRIN M, et al. Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts[J]. Transplantation, 2005, 80(10): 1501-1510. DOI: 10.1097/01.tp.0000178377.55615.8b.
|
[49] |
MOSCOSO I, HERMIDA-PRIETO M, MAÑEZ R, et al. Lack of cross-species transmission of porcine endogenous retrovirus in pig-to-baboon xenotransplantation with sustained depletion of anti-alphagal antibodies[J]. Transplantation, 2005, 79(7): 777-782. DOI: 10.1097/01.tp.0000152662.55720.83.
|
[50] |
CHEN G, QIAN H, STARZL T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys[J]. Nat Med, 2005, 11(12): 1295-1298. DOI: 10.1038/nm1330.
|
[51] |
YAMADA K, YAZAWA K, SHIMIZU A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1, 3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue[J]. Nat Med, 2005, 11(1): 32-34. DOI: 10.1038/nm1172.
|
[52] |
CHEN G, SUN H, YANG H, et al. The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy[J]. Transplantation, 2006, 81(2): 273-283. DOI: 10.1097/01.tp.0000188138.53502.de.
|
[53] |
EZZELARAB M, GARCIA B, AZIMZADEH A, et al. The innate immune response and activation of coagulation in alpha1, 3-galactosyltransferase gene-knockout xenograft recipients[J]. Transplantation, 2009, 87(6): 805-812. DOI: 10.1097/TP.0b013e318199c34f.
|
[54] |
LE BAS-BERNARDET S, TILLOU X, POIRIER N, et al. Xenotransplantation of galactosyl-transferase knockout, CD55, CD59, CD39, and fucosyl-transferase transgenic pig kidneys into baboons[J]. Transplant Proc, 2011, 43(9): 3426-3430. DOI: 10.1016/j.transproceed.2011.09.024.
|
[55] |
NISHIMURA H, SCALEA J, WANG Z, et al. First experience with the use of a recombinant CD3 immunotoxin as induction therapy in pig-to-primate xenotransplantation: the effect of T-cell depletion on outcome[J]. Transplantation, 2011, 92(6): 641-647. DOI: 10.1097/TP.0b013e31822b92a5.
|
[56] |
SPIEZIA L, BOLDRIN M, RADU C, et al. Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation[J]. Xenotransplantation, 2013, 20(2): 89-99. DOI: 10.1111/xen.12024.
|
[57] |
SEKIJIMA M, WAKI S, SAHARA H, et al. Results of life-supporting galactosyltransferase knockout kidneys in cynomolgus monkeys using two different sources of galactosyltransferase knockout swine[J]. Transplantation, 2014, 98(4): 419-426. DOI: 10.1097/TP.0000000000000314.
|
[58] |
AZIMZADEH AM, KELISHADI SS, EZZELARAB MB, et al. Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein[J]. Xenotransplantation, 2015, 22(4): 310-316. DOI: 10.1111/xen.12176.
|
[59] |
HIGGINBOTHAM L, MATHEWS D, BREEDEN CA, et al. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model[J]. Xenotransplantation, 2015, 22(3): 221-230. DOI: 10.1111/xen.12166.
|
[60] |
IWASE H, LIU H, WIJKSTROM M, et al. Pig kidney graft survival in a baboon for 136 days: longest life-supporting organ graft survival to date[J]. Xenotransplantation, 2015, 22(4): 302-309. DOI: 10.1111/xen.12174.
|
[61] |
RIVARD CJ, TANABE T, LANASPA MA, et al. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study[J]. Transpl Int, 2018, 31(10): 1164-1177. DOI: 10.1111/tri.13273.
|
[62] |
YAMAMOTO T, HARA H, FOOTE J, et al. Life-supporting kidney xenotransplantation from genetically engineered pigs in baboons: a comparison of two immunosuppressive regimens[J]. Transplantation, 2019, 103(10): 2090-2104. DOI: 10.1097/TP.0000000000002796.
|
[63] |
MA D, HIROSE T, LASSITER G, et al. Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques[J]. Am J Transplant, 2022, 22(1): 46-57. DOI: 10.1111/ajt.16780.
|
[64] |
IWASE H, JAGDALE A, YAMAMOTO T, et al. Evidence suggesting that deletion of expression of N-glycolylneuraminic acid (Neu5Gc) in the organ-source pig is associated with increased antibody-mediated rejection of kidney transplants in baboons[J]. Xenotransplantation, 2021, 28(4): e12700. DOI: 10.1111/xen.12700.
|